Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 1,946 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma
Interventions: Collaborative Agenda-Setting Intervention; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: Trastuzumab Deruxtecan; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 5
States / cities: Miami Beach, Florida • Tampa, Florida • Boston, Massachusetts + 2 more

Conditions: Autism Spectrum Disorder
Interventions: Joint Attention Intervention; Behavioral
Lead sponsor: Health Resources and Services Administration (HRSA); Federal
Eligibility: 24 Months to 60 Months
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 5
States / cities: Los Angeles, California • Tallahassee, Florida • Baltimore, Maryland + 2 more

Conditions: Exercise, Frailty, Arthritis, Accidental Falls
Interventions: Group Exercise, Behavioral Training; Behavioral
Lead sponsor: Iowa State University; Other
Eligibility: 65 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Diabetes Mellitus, Type 2
Interventions: Intervention 1- DSMS+, Comparison - DSMS; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 366 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Gainesville, Florida • Chicago, Illinois • Bedford, Massachusetts

Conditions: Psychotic Disorders, Schizoaffective Disorder, Schizophrenia
Interventions: Cognitive Behavioral Social Skills Training (CBSST), Goal Focused Supportive Contact (GFSC); Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 45 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: San Diego, California

Conditions: Cancer
Interventions: TTX-080, pembrolizumab, cetuximab, FOLFIRI; Drug
Lead sponsor: Tizona Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 41
States / cities: Tucson, Arizona • Los Angeles, California • Newport Beach, California + 37 more

Conditions: Schizophrenia and Related Disorders
Interventions: Cognitive Enhancement Therapy, Social Skills Training; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Hartford, Connecticut • Portland, Maine • Boston, Massachusetts + 1 more

Conditions: Adherence to Physical Activity After Completing Cardiac Rehabilitation (CR) in Older Adults
Interventions: Virtual Coaching and social support; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years to 100 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Colorectal Carcinoma
Interventions: NPT-PLA, Usual Quality Improvement; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Sleep Disturbance
Interventions: Targeted Approaches for Promoting Adolescent Sleep (TAPAS), Sleep Monitoring Only; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 13 Years to 15 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Lymphedema
Interventions: Flexitouch System, Hydroven FPR; Device
Lead sponsor: Tactile Medical; Industry
Eligibility: 18 Years and older
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 10
States / cities: Phoenix, Arizona • Chicago, Illinois • Springfield, Illinois + 7 more

Conditions: At Risk for AD-dementia, With Subjective Cognitive Decline
Interventions: HbAEx, HbExergame; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 65 Years to 99 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: AR11, Placebo; Drug
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 7
States / cities: Bradenton, Florida • Maitland, Florida • South Miami, Florida + 3 more

Conditions: Schizophrenia Spectrum Disorders, Psychotic Affective Disorders, Psychotic Mood Disorders, Homelessness, Ill-Housed Persons
Interventions: MI-CBTech, Mindfulness control; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: West Los Angeles, California

Conditions: Type 1 Diabetes
Interventions: iAPS, Sensor-Augmented Pump; Device · Other
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Santa Barbara, California • Rochester, Minnesota

Conditions: Arthroplasty, Replacement, Knee
Interventions: Comprehensive Behavioral Intervention, Standard of Care Exercise Program; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 50 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spina Bifida, Myelomeningocele
Interventions: Phase One: Exploration, Phase Two: Creation, Phase Three: Reflection, Aim 3; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 8 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cerebral Palsy
Interventions: Let's Move Motor Intervention; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 8 Months
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes, Chronic Diseases
Interventions: Self-Care Stimulating Disease Prevention Program, Fighting Cancer with Advice; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Diffuse Intrinsic Pontine Glioma, Glioma, Malignant
Interventions: Dordaviprone (ONC201); Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 8
States / cities: San Francisco, California • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Type 1 Diabetes
Interventions: Sleep Self-Management; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gastrointestinal Cancer
Interventions: Surgeon-palliative care team co management, Surgeon team alone management; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 5
States / cities: Stanford, California • Baltimore, Maryland • Boston, Massachusetts + 2 more

Conditions: Pulmonary Disease
Interventions: Institutional standard of care, Biosamples of airway and blood; Other
Lead sponsor: Boston University; Other
Eligibility: 46 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 19
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 13 more

Search by objective public record fields.

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Social and Communication Outcomes for Young Children With Autism

Evaluation of the Walk With Ease Program for Fall Prevention

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

Functional Rehabilitation of Older Patients With Schizophrenia

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)

Supportive Training After Cardiac Rehabilitation Including Virtual Engagement

Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents

Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema

Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults (The Exergames Telerehabilitation Study)

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI

Artificial Pancreas With Different Stress Assessments in the Outpatient Setting

The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA

Incontinence and Quality of Life in Children With Spina Bifida

Motor Training for Infants With Cerebral Palsy

Improving Health Habits in Impoverished Populations

ONC201 in Pediatric H3 K27M Gliomas

Self-Management in Young Adults With Type 1 Diabetes

Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers